🇺🇸 FDA
Pipeline program

SRP-9005

SRP-9005-101

Phase 3 mab terminated

Quick answer

SRP-9005 for Muscular Dystrophies, Limb-Girdle is a Phase 3 program (mab) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Sarepta Therapeutics
Indication
Muscular Dystrophies, Limb-Girdle
Phase
Phase 3
Modality
mab
Status
terminated

Clinical trials